MannKind Corporation - MNKD - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

MannKind Corporation - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
MNKD	Nasdaq	2834	http://www.mannkindcorp.com/	5.36 +0.05
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for MannKind Corporation ‘Love Hormone’ Promises Safer Births After Pfizer Flop - May 20th, 2013 4:20 pm Can Pfizer’s Love Hormone Cut Down Maternal Mortality? - May 20th, 2013 3:07 pm Oramed Sweeps Past Worldwide Giants With The First Trial Of Orally Delivered Insulin - May 19th, 2013 2:43 pm 5 of Last Week's Biggest Winners - May 19th, 2013 5:00 am 1 Giant Leap for MannKind - May 18th, 2013 10:45 am Why MannKind's Afrezza Will Succeed Where Pfizer Failed - May 18th, 2013 2:45 am MANNKIND CORP Financials - May 17th, 2013 11:04 am Activision Halts Vivendi Talks and 2 More Heavily Traded Stocks to Follow - May 15th, 2013 2:40 pm Coverage initiated on Mannkind by MLV & Co - May 14th, 2013 11:02 pm Narrower-than-Expected Loss at MannKind - May 13th, 2013 6:41 am 5 of Last Week's Biggest Winners - May 12th, 2013 5:15 am 3 Investment Strategy Lessons From Vertex's Success - May 11th, 2013 7:32 am MannKind 1Q loss widens on higher costs - May 10th, 2013 9:02 am MannKind 1Q loss widens on higher costs - May 10th, 2013 9:02 am MannKind's Countdown to Liftoff? - May 10th, 2013 8:50 am MANNKIND CORP Files SEC form 10-Q, Quarterly Report - May 10th, 2013 6:16 am MannKind Corporation's CEO Discusses Q1 2013 Results - Earnings Call Transcript - May 9th, 2013 5:58 pm MannKind Earnings Call scheduled for 5:00 pm ET today - May 9th, 2013 3:00 pm 3 Drug Catalysts to Watch in 2013 - May 9th, 2013 2:29 pm MannKind Corporation Reports 2013 First Quarter Financial Results - May 9th, 2013 2:00 pm View All Current Headlines >>